Vanessa Poliquin1, Devon Greyson2, Eliana Castillo3. 1. Department of Obstetrics, Gynecology, and Reproductive Sciences, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB. Electronic address: vpoliquin@hsc.mb.ca. 2. Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC; Department of Pediatrics, University of British Columbia, Vancouver, BC. 3. Department of Medicine, University of Calgary, Calgary, AB; Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB.
Abstract
OBJECTIVE: Although vaccination in pregnancy has the potential to affect maternal and infant morbidity and mortality dramatically, uptake of recommended vaccinations in pregnancy remains low. The objective of this study was to identify barriers and facilitators of vaccination during pregnancy in Canada. METHODS: The Medline database and the tables of contents of four relevant Canadian journals were screened to identify all studies that considered barriers and/or facilitators to vaccination during pregnancy, specifically in Canadian settings. Citations were screened, and a narrative synthesis of findings was undertaken given the heterogeneity of study design. RESULTS: In total, 17 studies met inclusion criteria, most with a focus on the seasonal and pandemic influenza vaccines. Facilitators and barriers were identified at the level of the patient and the provider. At both levels, knowledge was an important facilitator of vaccine acceptance during pregnancy and was notably improved in studies following the 2009 pandemic H1N1 influenza outbreak compared with earlier studies. Vaccine endorsement by a prenatal care provider and clear messages of safety for the fetus emerged as key motivators. Few studies addressed system-level barriers or interventions for improving vaccine uptake during pregnancy in the Canadian setting. CONCLUSION: Common themes have emerged from the Canadian literature addressing barriers and facilitators of vaccination during pregnancy. However, there is a paucity of literature to suggest strategies to improve the uptake of vaccination during pregnancy in Canadian settings. Further research is urgently needed given the expanding role of vaccination during routine prenatal care.
OBJECTIVE: Although vaccination in pregnancy has the potential to affect maternal and infant morbidity and mortality dramatically, uptake of recommended vaccinations in pregnancy remains low. The objective of this study was to identify barriers and facilitators of vaccination during pregnancy in Canada. METHODS: The Medline database and the tables of contents of four relevant Canadian journals were screened to identify all studies that considered barriers and/or facilitators to vaccination during pregnancy, specifically in Canadian settings. Citations were screened, and a narrative synthesis of findings was undertaken given the heterogeneity of study design. RESULTS: In total, 17 studies met inclusion criteria, most with a focus on the seasonal and pandemic influenza vaccines. Facilitators and barriers were identified at the level of the patient and the provider. At both levels, knowledge was an important facilitator of vaccine acceptance during pregnancy and was notably improved in studies following the 2009 pandemic H1N1 influenza outbreak compared with earlier studies. Vaccine endorsement by a prenatal care provider and clear messages of safety for the fetus emerged as key motivators. Few studies addressed system-level barriers or interventions for improving vaccine uptake during pregnancy in the Canadian setting. CONCLUSION: Common themes have emerged from the Canadian literature addressing barriers and facilitators of vaccination during pregnancy. However, there is a paucity of literature to suggest strategies to improve the uptake of vaccination during pregnancy in Canadian settings. Further research is urgently needed given the expanding role of vaccination during routine prenatal care.
Authors: Laura Reifferscheid; Emmanuel Marfo; Ali Assi; Eve Dubé; Noni E MacDonald; Samantha B Meyer; Julie A Bettinger; S Michelle Driedger; Joan Robinson; Manish Sadarangani; Sarah E Wilson; Karen Benzies; Samuel Lemaire-Paquette; Arnaud Gagneur; Shannon E MacDonald Journal: Can J Public Health Date: 2022-04-27
Authors: Sarah Geoghegan; Laura C Stephens; Kristen A Feemster; Richard J Drew; Maeve Eogan; Karina M Butler Journal: Hum Vaccin Immunother Date: 2021-05-19 Impact factor: 3.452